Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Ambion Library)
Assay data:9227 Active, 64752 Tested
SummaryPubMed Citation
RNAi screen for vorinostat resistance genes - Primary Screen
Assay data:450 Active, 18118 Tested
Druggable Genome siRNA Screen for Enhancers of Camptothecin in MDA-MB-231 Breast Cancer Cells
Assay data:167 Active, 26449 Tested
Summary
Late stage assay provider screen for the probe development effort to identify inhibitors of PP1: radiolabel-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP1
Assay data:2 Active, 4 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late stage assay provider screen for the probe development effort to identify inhibitors of PP1: radiolabel-based biochemical assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP1
Assay data:5 Active, 15 Tested
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP1: radiolabel-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of glycogen phosphorylase by PP1, Set 2
Assay data:5 Active, 5 Tested
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP1: radiolabel-based biochemical assay to determine activity of inhibitors on dephosphorylation of glycogen phosphorylase by PP1, Set 2
Assay data:5 Active, 65 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP1: fluorescence-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of OMFP by PP1, Set 1
Assay data:18 Active, 1 Activity ≤ 1 µM, 18 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late stage assay provider results from the probe development effort to identify inhibitors of PP1: fluorescence-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of OMFP by PP1, Set 3
Assay data:2 Active, 2 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP1: fluorescence-based biochemical assay to determine activity of inhibitors on dephosphorylation of OMFP by PP1, Set 2
Assay data:31 Active, 36 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP1: fluorescence-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of OMFP by PP1, Set 4
Assay data:3 Active, 4 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP1: fluorescence-based biochemical assay to determine activity of inhibitors on dephosphorylation of OMFP by PP1, Set 3
Assay data:32 Active, 64 Tested
Late stage assay provider results from the probe development effort to identify inhibitors of PP1: fluorescence-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of OMFP by PP1, Set 2
Assay data:5 Active, 6 Tested
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP1: radiolabel-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of glycogen phosphorylase by PP1
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP1: radiolabel-based biochemical assay to determine activity of inhibitors on dephosphorylation of glycogen phosphorylase by PP1
Late stage assay provider results from the probe development effort to identify inhibitors of PP1: fluorescence-based biochemical assay to determine activity of inhibitors on dephosphorylation of OMFP by PP1
A whole genome RNAi screen highlights components of the ER/Golgi as a prominent source of resistance to immunotoxin-mediated cytotoxicity
Assay data:555 Active, 64752 Tested
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Dharmacon Library)
Assay data:826 Active, 18119 Tested
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical dose response assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP1 (Round 5)
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late stage assay provider counterscreen for the probe development effort to identify inhibitors of PP5: radiolabel-based biochemical assay to determine activity of inhibitors on dephosphorylation of phosphohistone by PP1 (Round 5)
Assay data:7 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on